Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study.

Journal of medical virology - 1 Jan 2023

Baranova Ancha, Cao Hongbao, Zhang Fuquan

Abstract excerpt

It was reported that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may cause brain size reduction and cognitive decline. Whether COVID-19 may contribute to the development of Alzheimer's disease (AD) is not known. We conducted genetic correlation and Mendelian randomization (MR) analyses to assess genetic relationships and potential causal associations between AD and three COVID-19...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Bioinformatics and Genomic Networks
Share to COVID-19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Associations and Epidemiology

Share to Genome-Wide Association Study

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 36039844
DOI: 10.1002/jmv.28107
PMCID: PMC9539282

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study.PMID 36039844Read ↗

Association between Alzheimer’s disease and COVID-19: A bidirectional Mendelian randomizationSemantic proximity Read ↗

COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization studySemantic proximity Read ↗

COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.Semantic proximity Read ↗

Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.Semantic proximity Read ↗

COVID ‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosisSemantic proximity Read ↗

Shared Genetic Architecture Between COVID-19 Severity and Alzheimer's Disease Across European and African AncestriesSemantic proximity Read ↗

Shared Genetic Architecture Between COVID-19 Severity and Alzheimer's Disease Across European and African AncestriesSemantic proximity Read ↗

Causal associations and genetic overlap between COVID-19 and intelligence.Semantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform based on Mendelian randomization analysis——MRADSemantic proximity Read ↗

Shared genetics and causal associations between COVID-19 and multiple sclerosis.Semantic proximity Read ↗

Causal relationship of COVID-19 on Alzheimer’s disease: an updated Mendelian randomization studySemantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform MRAD developed based on Mendelian randomization analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.